Literature DB >> 35399180

Role and Efficacy of Robotic-assisted Radical Antegrade Modular Pancreatosplenectomy (RAMPS) in Left-sided Pancreatic Cancer.

Eleandros Kyros1,2, Spyridon Davakis1,2, Alexandros Charalabopoulos1,2, Gerasimos Tsourouflis2,3, Alexandros Papalampros1, Evangelos Felekouras1, Nikolaos Nikiteas2,3.   

Abstract

Distal pancreatectomy with splenectomy is the gold-standard surgery for the treatment of left-sided pancreatic cancer. Margin negative resection accompanied by effective lymphadenectomy are the deciding factors affecting the outcome of tail-body pancreatic adenocarcinoma. Radical antegrade modular pancreatosplenectomy (RAMPS) is considered as a reasonable approach for margin-negative and systemic lymph node clearance. Herein, we aim to present all existing data regarding this novel approach including surgical technique and comparison with standardized procedures. RAMPS has shown oncological superiority comparing to distal pancreatectomy with splenectomy due to radical lymphadenectomy and improved dissection of the posterior pancreatic aspects. Robotic-assisted RAMPS has recently been described as a valuable alternative to open RAMPS. With this novel technique, anterior, posterior or modified approaches can be achieved; favorable clinical and oncological outcomes have been reported in the current literature, with reduced conversion rates compared to other minimally invasive approaches, as well as vastly improved maneuverability, accuracy and vision. Robotic-assisted RAMPS is not only technically feasible but also oncologically safe in cases of well-selected, left-sided pancreatic cancer. Copyright 2022, International Institute of Anticancer Research.

Entities:  

Keywords:  Pancreatic cancer; adenocarcinoma; distal pancreatectomy; radical antegrade modular pancreatosplenectomy; review; robotic-assisted RAMPS

Year:  2022        PMID: 35399180      PMCID: PMC8962807          DOI: 10.21873/cdp.10088

Source DB:  PubMed          Journal:  Cancer Diagn Progn        ISSN: 2732-7787


  36 in total

1.  Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes.

Authors:  Sung Hwan Lee; Chang Moo Kang; Ho Kyoung Hwang; Sung Hoon Choi; Woo Jung Lee; Hoon Sang Chi
Journal:  Surg Endosc       Date:  2014-05-23       Impact factor: 4.584

2.  Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma.

Authors:  Marianne Huebner; Michael Kendrick; Kaye M Reid-Lombardo; Florencia Que; Terry Therneau; Rui Qin; John Donohue; David Nagorney; Michael Farnell; Michael Sarr
Journal:  J Gastrointest Surg       Date:  2012-03-16       Impact factor: 3.452

Review 3.  A systematic review of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas.

Authors:  Yanming Zhou; Bin Shi; Lupeng Wu; Xiaoying Si
Journal:  HPB (Oxford)       Date:  2016-08-21       Impact factor: 3.647

4.  Laparoscopic distal pancreatectomy.

Authors:  A Lebedyev; O Zmora; J Kuriansky; D Rosin; M Khaikin; M Shabtai; A Ayalon
Journal:  Surg Endosc       Date:  2004-08-24       Impact factor: 4.584

5.  Meta-analysis of short-term outcomes comparing robot-assisted and laparoscopic distal pancreatectomy.

Authors:  Yong-Hao Hu; Ya-Fei Qin; Ding-Ding Yu; Xiang Li; Yi-Ming Zhao; De-Jun Kong; Wang Jin; Hao Wang
Journal:  J Comp Eff Res       Date:  2020-01-24       Impact factor: 1.744

6.  A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate?

Authors:  David A Kooby; William G Hawkins; C Max Schmidt; Sharon M Weber; David J Bentrem; Theresa W Gillespie; Johnita Byrd Sellers; Nipun B Merchant; Charles R Scoggins; Robert C G Martin; Hong Jin Kim; Syed Ahmad; Clifford S Cho; Alexander A Parikh; Carrie K Chu; Nicholas A Hamilton; Courtney J Doyle; Scott Pinchot; Amanda Hayman; Rebecca McClaine; Attila Nakeeb; Charles A Staley; Kelly M McMasters; Keith D Lillemoe
Journal:  J Am Coll Surg       Date:  2010-05       Impact factor: 6.113

Review 7.  Robotic versus laparoscopic distal pancreatectomy - The first meta-analysis.

Authors:  Paschalis Gavriilidis; Chetana Lim; Benjamin Menahem; Eylon Lahat; Chady Salloum; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2016-05-20       Impact factor: 3.647

8.  Surgical strategy for patients with pancreatic body/tail carcinoma: who should undergo distal pancreatectomy with en-bloc celiac axis resection?

Authors:  Ken-ichi Okada; Manabu Kawai; Masaji Tani; Seiko Hirono; Motoki Miyazawa; Atsushi Shimizu; Yuji Kitahata; Hiroki Yamaue
Journal:  Surgery       Date:  2012-10-06       Impact factor: 3.982

9.  Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.

Authors:  Thijs de Rooij; Johanna A Tol; Casper H van Eijck; Djamila Boerma; Bert A Bonsing; Koop Bosscha; Ronald M van Dam; Marcel G Dijkgraaf; Michael F Gerhards; Harry van Goor; Erwin van der Harst; Ignace H de Hingh; Geert Kazemier; Joost M Klaase; I Quintus Molenaar; Gijs A Patijn; Hjalmar C van Santvoort; Joris J Scheepers; George P van der Schelling; Egbert Sieders; Olivier R Busch; Marc G Besselink
Journal:  Ann Surg Oncol       Date:  2015-10-27       Impact factor: 5.344

Review 10.  Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions.

Authors:  Maximilian Brunner; Zhiyuan Wu; Christian Krautz; Christian Pilarsky; Robert Grützmann; Georg F Weber
Journal:  Int J Mol Sci       Date:  2019-09-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.